Pioneer Invest (507864)
Asset PlayScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹48.55 |
| Market Cap | ₹59.7 Cr |
| P/E Ratio | 6.97 |
| ROCE | 8.82% |
| ROE | 6.77% |
| Dividend Yield | 0% |
| Profit Growth | 286.58% |
| Debt/Equity | — |
| Sales Growth | 23.5% |
| 52-Week Range | ₹59.41 — ₹133.9 |
| Sector | Finance |
| Book Value | ₹115.06 |
Strengths
- P/B of 0.42 offers a deep discount to book value of ₹115.06, providing a Graham-style margin of safety.
- P/E of 6.97 is low on reported earnings, and the Piotroski F-Score of 7/9 suggests reasonably sound financials.
- Sales growth of 23.50% and latest quarter net profit of ₹6 Cr indicate some near-term momentum.
- Small market cap and asset-heavy financial-services profile may attract value buyers seeking hidden asset value.
Concerns
- ROE of 6.77% and ROCE of 8.82% are mediocre, meaning the book value is not compounding at an attractive rate.
- Zero dividend yield means minority shareholders receive no income while waiting for value realisation.
- Current price of ₹48.55 is below the 52-week range low of ₹59.41, signalling severe market distrust or deteriorating conditions.
- Profit growth of 286.58% and a 50% net margin in the latest quarter may be non-recurring, not sustainable operating quality.
AI Analysis
At ₹48.55, this is a micro-cap financial services company with a market cap of merely ₹60 Cr. The first thing that catches my eye is the price-to-book ratio of 0.42 against a book value of ₹115.06. Graham taught us to buy a rupee of assets for 40 paise, so the margin of safety appears wide on the balance sheet. But cheapness must always be weighed against earning power. ROE is only 6.77% and ROCE is 8.82%: the underlying assets are not compounding at a rate that would excite a long-term owner. The reported profit growth of 286.58% looks remarkable, but it comes off a small base, and the latest quarter shows ₹12 Cr in sales producing ₹6 Cr in net profit — a 50% margin that suggests non-recurring gains rather than durable operating strength. I cannot give full credit to that figure in my valuation. The P/E of 6.97 is low, and the Piotroski F-Score of 7/9 is a positive check on financial health. There is no dividend, so shareholders are not being paid to wait while the market reprices the stock. What worries me more is that the current price of ₹48.55 is actually below the stated 52-week range of ₹59.41 to ₹133.90 — the market is deeply fearful. Promoter holding is undisclosed, and at ₹60 Cr market cap, liquidity is thin. This looks more like an asset play than a growing franchise: you are buying assets at a discount, but those assets earn mediocre returns and capital allocation remains unproven. I would wait for either a higher durable ROE or evidence that management is releasing value through dividends, buybacks, or a strategic action.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer